GABA Guide — What 1,485 Notifications Show About Use and Dosing

GABA 原料イメージ
In shortGABA (gamma-aminobutyric acid, CAS 56-12-2) is the most widely used functional ingredient in Japan’s Foods with Function Claims — 1,485 notifications across 611 companies. But 507 of those 1,485 are combination notifications: GABA is used less as the headline than as a base to build other claims on. In sourcing, the point is to settle the daily intake first — 100 mg is the most common notified dose, but designs at 28 mg and 12.3 mg are also numerous, and the quantity you need shifts by an order of magnitude.

What GABA is

GABA is short for gamma-aminobutyric acid, an amino acid. It occurs in germinated brown rice and tomatoes among other foods, with a long history of dietary consumption. The research base is exceptionally deep: 11,457 papers on J-STAGE, 2,005 of them from 2020 onward.

It is not a food additive. GABA appears in neither of the lists we maintain — 476 designated additives and 327 existing additives — and is handled as a food raw material.

In the notification data — Japan’s most used functional ingredient

Aggregating the Consumer Affairs Agency’s Foods with Function Claims notifications by functional ingredient name, GABA totals 1,485 notifications across 611 companies — the highest for any single ingredient, by a wide margin.

The breakdown tells you what kind of ingredient it is.

  • GABA alone — 978 notifications
  • Combined with other ingredients — 507 (about one third)

The partners are varied: Apocynum-derived hyperoside, olive-derived hydroxytyrosol, lycopene, indigestible dextrin, lutein and zeaxanthin, black ginger-derived polymethoxyflavone, DHA and EPA, L-theanine, spore-forming lactic acid bacteria, and more.

In other words, GABA is chosen less as a material to sell on its own than as a base layered under another claim. Keeping that position in mind at the planning stage speeds up both the formulation and the positioning.

The claims being notified

Notified function claims fall into two directions.

  • Blood pressure — “GABA has been reported to have a function of lowering blood pressure in those with elevated blood pressure” (95 notifications)
  • Sleep — “a function that helps improve sleep quality (depth of sleep, refreshed waking)” (24)

One material, two exits. Decide which one you are going to market before fixing the dose; the other order leaves the research review used as evidence out of step with the daily intake reference. Permissible wording and intake reference differ by notification, and notification is filed on the responsibility of the notifying party.

The quantity shifts by an order of magnitude — 100 mg or 12.3 mg

Notified content per daily intake reference, most common first:

  • 100 mg — 376 notifications (notation variants combined)
  • 28 mg — 102
  • 12.3 mg — 57

100 mg against 12.3 mg is an eight-fold difference. Annual requirements change completely, so compare on cost per daily dose, not unit price. And at a low inclusion such as 12.3 mg, content uniformity in tableting becomes the issue — a premix with excipient may be required.

Which dose you choose is decided together with the claim above. Settling the intended quantity before requesting quotations makes the comparison faster.

Fermented or synthetic — a positioning question, not an evidence question

Both fermentation-derived and chemically synthesised GABA are in circulation. FONTIA supplies GABA (synthetic) and fermented GABA; both are CAS 56-12-2 — the same substance.

One distinction is worth drawing. Searching J-STAGE for “fermented GABA” returns 7 papers; searching for “GABA” returns 11,457. The research base attaches to the substance, not to the production route.

Choosing the fermented grade is therefore a product-planning decision — natural-origin positioning, how the ingredient list reads — not a way to strengthen the evidence for a claim. Leave that distinction blurred and the price difference becomes impossible to justify.

What to confirm on the specification

  • Production method — fermentation or synthesis. Bears on positioning and ingredient labelling, and explains the price difference
  • Content — purity as GABA. At low inclusion, content variation feeds straight into formulation accuracy
  • Particle size — for tableting or powder filling. At a low dose such as 12.3 mg, confirm whether a premix is needed
  • Hygroscopicity — as an amino acid, handling after opening needs care
  • Heavy metals and purity tests — compendial or in-house specification
  • COA per lot — confirm the format and availability in advance

Discussing your requirement

For specifications, samples or a quotation, use the contact form and include the production method (fermented or synthetic), intended daily dose, and claim direction (blood pressure or sleep). If you are planning a combination, tell us the partner ingredient as well and we can cover the formulation points too.

Related: functional ingredients

FAQ

Which is better, fermented or synthetic GABA?

Both are CAS 56-12-2 — the same substance. The research base attaches to GABA itself (11,457 papers on J-STAGE, against 7 for “fermented GABA”), so the production route does not change the evidence for a claim. Fermented grade is chosen for positioning and how the ingredient list reads, and that is where the price difference sits.

What daily intake is typical?

100 mg is the most notified (376), with 28 mg (102) and 12.3 mg (57) also numerous — an eight-fold range. Compare on cost per daily dose rather than unit price.

What claims are being notified?

Two directions: blood pressure (“lowering blood pressure in those with elevated blood pressure”) at 95 notifications, and sleep (“helps improve sleep quality”) at 24. Decide which one you are going to market before fixing the dose.

Can it be combined with other ingredients?

507 of the 1,485 notifications are combinations — with Apocynum-derived components, theanine, lactic acid bacteria, lutein and zeaxanthin, among many others. Tell us the partner ingredient and we can advise on formulation points.

Is it a food additive?

No. It appears in neither of the lists we maintain — 476 designated additives and 327 existing additives — and is handled as a food raw material.

Will it blend uniformly at low inclusion?

At a low dose such as 12.3 mg, content uniformity becomes the issue and a premix with excipient may be required. Tell us your intended quantity early.

Need a quote or sample of GABA (Gamma-Aminobutyric Acid)?

We can send the specification, MOQ and lead time for this ingredient.

View this ingredient Contact form

Or email us: